21
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Antisense Oligonucleotides Complementary to Bax Transcripts Reduce the Susceptibility of B-cell Chronic Lymphocytic Leukaemia Cells to Apoptosis in a Bcl-2 Independent Manner

, , &
Pages 2003-2009 | Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bela Bodey, Bela Bodey Jr & Stuart E Siegel. (2005) Mechanisms and markers of carcinogenesis and neoplastic progression. Expert Opinion on Biological Therapy 5:10, pages 1317-1332.
Read now

Articles from other publishers (4)

Chris Fegan & Chris Pepper. 2013. Advances in Chronic Lymphocytic Leukemia. Advances in Chronic Lymphocytic Leukemia 151 171 .
Graham Packham & Freda K. Stevenson. (2005) Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology 114:4, pages 441-449.
Crossref
Jane Starczynski, Chris Pepper, Guy Pratt, Laura Hooper, Alun Thomas, Donald Milligan, Paul Bentley & Christopher Fegan. (2005) Common Polymorphism G(-248)A in the Promoter Region of the bax Gene Results in Significantly Shorter Survival in Patients With Chronic Lymphocytic Leukemia Once Treatment Is Initiated . Journal of Clinical Oncology 23:7, pages 1514-1521.
Crossref
Lian-Jie Lin. (2003) Expression of survivin protein in human colorectal carcinogenesis. World Journal of Gastroenterology 9:5, pages 974.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.